Cargando…

366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay

BACKGROUND: Allergic contact dermatitis (ACD) to topical medicaments is common. Medicaments are responsible for approximately 30% of all cases of ACD. The most common drugs associated with ACD include topically applied antibiotics, antiseptics, antihistamines, anesthetics, nonsteroidal antiinflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomies, Valeria, Ale, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512916/
http://dx.doi.org/10.1097/01.WOX.0000412129.56769.f6
_version_ 1782251832243912704
author Pomies, Valeria
Ale, Iris
author_facet Pomies, Valeria
Ale, Iris
author_sort Pomies, Valeria
collection PubMed
description BACKGROUND: Allergic contact dermatitis (ACD) to topical medicaments is common. Medicaments are responsible for approximately 30% of all cases of ACD. The most common drugs associated with ACD include topically applied antibiotics, antiseptics, antihistamines, anesthetics, nonsteroidal antiinflammatory drugs, and corticosteroids. Certain body areas are particularly susceptible (ie, genital and perianal areas, ears, eyes, face and lower legs) Predisposing factors are: occlusion (skin folds, use of bandages), application in damaged skin (stasis dermatitis & leg ulcers, and other chronic dermatitis) and long-lasting use of multiple medicaments The aim of our study was to study the prevalence of ACD to topical medicaments in patients with suspected ACD attending the Unit of Allergy at the University Hospital in Montevideo. METHODS: 1175 consecutive patients; 781 F (63%) 394 M (37%) with suspected ACD were patch tested with the standard series and the topical medicament series, as well as other allergens according to the clinical situation. RESULTS: The most frequent allergens were: Neomycin (7.1%), Thiomersal (3.8%), Benzocaine (1.9%), Bacitracin (1.9%), Propolis (1.5%), Gentamycin (1.2%), Tixocortol (1.1%) and Budesonide 24 (0.8%). CONCLUSIONS: Contact allergy to topical medicaments is common in patients studied by a suspected ACD in Uruguay. In these cases the topical medicaments that the patient is using should be included when patch testing.
format Online
Article
Text
id pubmed-3512916
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35129162012-12-21 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay Pomies, Valeria Ale, Iris World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Allergic contact dermatitis (ACD) to topical medicaments is common. Medicaments are responsible for approximately 30% of all cases of ACD. The most common drugs associated with ACD include topically applied antibiotics, antiseptics, antihistamines, anesthetics, nonsteroidal antiinflammatory drugs, and corticosteroids. Certain body areas are particularly susceptible (ie, genital and perianal areas, ears, eyes, face and lower legs) Predisposing factors are: occlusion (skin folds, use of bandages), application in damaged skin (stasis dermatitis & leg ulcers, and other chronic dermatitis) and long-lasting use of multiple medicaments The aim of our study was to study the prevalence of ACD to topical medicaments in patients with suspected ACD attending the Unit of Allergy at the University Hospital in Montevideo. METHODS: 1175 consecutive patients; 781 F (63%) 394 M (37%) with suspected ACD were patch tested with the standard series and the topical medicament series, as well as other allergens according to the clinical situation. RESULTS: The most frequent allergens were: Neomycin (7.1%), Thiomersal (3.8%), Benzocaine (1.9%), Bacitracin (1.9%), Propolis (1.5%), Gentamycin (1.2%), Tixocortol (1.1%) and Budesonide 24 (0.8%). CONCLUSIONS: Contact allergy to topical medicaments is common in patients studied by a suspected ACD in Uruguay. In these cases the topical medicaments that the patient is using should be included when patch testing. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512916/ http://dx.doi.org/10.1097/01.WOX.0000412129.56769.f6 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Pomies, Valeria
Ale, Iris
366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
title 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
title_full 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
title_fullStr 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
title_full_unstemmed 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
title_short 366 Contact Allergy to Medicaments in Consecutively Patch-tested Patients in Uruguay
title_sort 366 contact allergy to medicaments in consecutively patch-tested patients in uruguay
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512916/
http://dx.doi.org/10.1097/01.WOX.0000412129.56769.f6
work_keys_str_mv AT pomiesvaleria 366contactallergytomedicamentsinconsecutivelypatchtestedpatientsinuruguay
AT aleiris 366contactallergytomedicamentsinconsecutivelypatchtestedpatientsinuruguay